
The common antibiotic that could leave you wheelchair-bound
I know this first hand. I'm Nathan Kay, a journalist and editor. I've worked for publications such as The Mail on Sunday, Daily Express and CNN, covering everything from royal news to celebrity gossip. I was a regular 40-something-year-old, living in the city, healthy and active, swimming and gyming regularly, working in a high-stress job. I had a career I loved and a life I was proud of.
That was until the day I took an antibiotic that I thought was nothing more than a routine prescription – Ciprofloxacin, a common fluoroquinolone. What followed was a descent into chronic pain, brain fog, and fatigue that I couldn't shake. My life, my career and my relationships were completely altered by an antibiotic more powerful than I could ever have imagined.
I am one of the thousands affected by what's known as fluoroquinolone toxicity, or 'being floxed.' It's a term used by patients who have suffered severe, sometimes permanent side effects from these antibiotics. And it's growing. Studies show that fluoroquinolones are prescribed more than 20,000 times a month in the UK, and while the majority of people experience no lasting effects, an alarming number of others, like me, find their lives permanently altered.
A significant portion of those affected by fluoroquinolone toxicity, as many as 15 per cent (according to some estimates), experience debilitating symptoms that can persist long after the drug is discontinued, with some patients struggling to find effective treatment. The psychological toll is often ignored, yet research shows a strong correlation between fluoroquinolone use and mental health issues, including depression and suicide. GPs are essentially playing Russian roulette with patient health by prescribing these drugs without fully acknowledging or preparing patients for the life-altering risks they may face.
This article aims to highlight the growing problem, with first-hand accounts from patients whose lives have been destroyed by these antibiotics, supported by expert opinions and statistics showing just how many lives are being impacted.
The growing issue: What are fluoroquinolones?
Fluoroquinolones are a class of broad-spectrum antibiotics often used to treat a variety of bacterial infections. They include well-known medications such as Ciprofloxacin, Levofloxacin, and Moxifloxacin, and are highly effective, able to penetrate different areas of the body to fight infections in the bladder, lungs and skin, among others.
Their strength makes them invaluable for certain serious infections – but also potentially dangerous. Professor Munir Pirmohamed, 62, a consultant physician at the Royal Liverpool Hospital and leading pharmacogenetics expert at the University of Liverpool, explains: 'They interfere with the normal functioning of the bacterial cell by inhibiting two main enzymes, DNA gyrase and Topoisomerase IV. The bacteria cannot repair their DNA, and this kills the bacterial cells.'
From the start, he notes, it has been known that they can cause tendon problems, most often with the Achilles. But the damage can go further: 'There is concern about FQAD [Fluoroquinolone-Associated Disability]. In some people, FQAD represents a life-changing event. The severity, recovery and prognosis vary. There are many theories why these drugs cause the problem, including effects on mitochondria and on the immune system, but none have been proven.'
Though fluoroquinolones are prescribed regularly, the risk associated with them is often underestimated. In 2024, the MHRA (Medicines and Healthcare products Regulatory Agency) issued updated guidelines advising that these antibiotics should only be prescribed when other first-line treatments are unsuitable or ineffective. Despite this, there are still over 20,000 prescriptions written for Ciprofloxacin each month in the UK alone.
The concerns: The dark side of Fluoroquinolones
Fluoroquinolones have been linked to devastating side effects, leaving many patients disabled and in a state of constant suffering. The impact can be profound, with some experiencing chronic pain, fatigue and neurological disorders, all of which can dramatically alter quality of life. For some, the consequences are so severe that they lead to thoughts of suicide.
The concern with fluoroquinolones isn't just that they have the potential to cause discomfort – the risks can be life-altering.
For 49-year-old recruitment consultant Victoria Abotorabi from Leeds, the consequences were devastating when, in 2024, she was prescribed Ciprofloxacin with prednisolone for a suspected sinus infection.
'The out-of-hours ENT didn't make me aware of the potential side effects – neither did the pharmacy.'
Five days in she had pins and needles, and numb arms and hands. A&E checked her heart but not her medication. Two weeks later, she woke with severe head pain and pressure. Tests followed – an MRI and lumbar puncture – but still no review of her antibiotics. At one point, she recalls, 'every single muscle in my body went into spasm.'
Victoria's symptoms escalated to the point where she became housebound, and unable to work or care for her children. 'This has completely devastated my life,' she says. 'I have lost my physical and mental health. I have severe PTSD, depression, chronic pain and a diagnosis of fibromyalgia, dysautonomia, FND and digestive issues… A year later, I am still struggling.'
She has been referred to a mental health crisis team after suicidal thoughts.
'I couldn't stop crying… I was in so much pain and so scared I was dying, and no one could help me. I tried to end my life because I was in so much physical pain. I have never thought about suicide before.'
The psychiatric risks are stark. In one high-profile case, respected cardiologist Dr Robert Stevenson died by suicide shortly after starting Ciprofloxacin. A coroner concluded the drug's psychiatric effects – including depression and suicidal thoughts – contributed to his death.
The science behind the damage
Dr Richard Berwick, 36, consultant in pain medicine at the Walton Centre and a Versus Arthritis clinical training fellow at the University of Liverpool, explains one theory as to why fluoroquinolones may be particularly harmful because of their ability to damage cells at the mitochondrial level. 'During an FQ toxicity reaction, cell mitochondria (the cell powerhouse) might be disrupted, causing cells to become injured, especially nerves and muscles. They can also block nerve channels leading to altered brain function,' he explains.
This disruption can lead to long-term symptoms that continue long after the medication is stopped. As Dr Thuva Amuthan, 34, a general practitioner, further elaborates: 'Even a short course can, in rare cases, lead to long-term problems with tendons, muscles, joints, nerves and sometimes mood and memory. Early recognition of symptoms is vital.'
The people suffering from a lifelong struggle
For me, fluoroquinolone toxicity left me virtually bedridden for six months, unable to move and feeling poisoned. I've improved to about 80 per cent of my previous health, but never fully recovered. At the same time, a quad bike accident left me with multiple fractures, compounding my ongoing pain. Outwardly, I may look fine, but daily fatigue and discomfort remain constant companions.
For Myles Washington, 38, a former personal trainer from the Isle of Wight, the ordeal began at 14, when he was given a fluoroquinolone for what was likely an allergy. At 24, he was prescribed another course for a misdiagnosed condition.
'It completely destroyed my health and changed the course of my life,' he says. 'I lost my career, my dreams and my identity.'
He has since endured torn ligaments, chronic fatigue, tendon ruptures and nerve symptoms. 'This isn't just a temporary side effect,' he says. 'It's long-term, progressive damage.'
Jeremy Maddock, 57, who runs an architectural practice in Devon, was floxed after taking Ciprofloxacin for a presumed infection. The side effects left him crawling upstairs and barely able to walk. 'The pain has moved around nearly every part of my body. I suffered psychological stress and suicidal ideation way beyond the normal realms of anxiety.'
Years later he lives more normally, but must take extreme care to avoid relapse. He credits the Fluoroquinolone Toxicity Support UK Facebook group with 'probably saving lives.'
Treatment – or the lack of it
There is no standard treatment protocol for fluoroquinolone toxicity. Dr Berwick says supportive care is key, with therapies to help people live better despite symptoms. Some may use anti-neuropathic painkillers, though these bring their own side effects.
Only one specialist in England can formally diagnose the condition. Many patients, says Fluoroquinolone Toxicity Support UK Facebook group co-founder Miriam Knight, 73, are steered towards expensive, unproven alternative therapies. 'Steer very well clear,' she advises. 'There are absolutely no guarantees except that the clinic will make money.'
Professor Pirmohamed agrees, adding that: 'Many people are being offered untested and untried treatments, which can be expensive and potentially dangerous. I am not convinced there is enough evidence to recommend them.'
I've tried B12 injections and quarterly vitamin-and-magnesium IV treatments myself. They help briefly, but offer no long-term fix.
What's next? The road to change
Research is underway, but funding is scarce. Professor Pirmohamed calls for dedicated investment to define the condition, identify genetic risk factors and develop diagnostic tests and treatments – all with strong patient involvement.
I took part in the APIF study into autoimmune phenotyping in fibromyalgia, run by the University of Liverpool and The Walton Centre NHS University Hospital. Dr Berwick explains that he observed two fluoroquinolone toxicity patients in the study had temperature sensitivity, which is often seen in fibromyalgia. He noticed that the participants who develop fibromyalgia-type syndromes after fluoroquinolones report heightened cold sensitivity, and cold exposure can exacerbate pain. It's a link that suggests there could be an affected sensory-nerve or central-sensitisation pathway in fluoroquinolone toxicity patients, and researchers are now actively investigating that.
Genetics may also play a role, making some people inherently more prone to long-term reactions.
What can you do?
If prescribed a fluoroquinolone, ask about alternatives. Ensure your doctor knows of any conditions that may make you more vulnerable. When you're offered a fluoroquinolone, ask your GP whether safer first-line antibiotics are suitable – and check for red-flag risk factors if you're aged over 60, suffer from renal impairment, have been diagnosed with fibromyalgia, suffer from autoimmune diseases, have a history of tendon problems or have had an organ transplant. These groups face higher odds of serious side effects. If you take a fluoroquinolone, report any tendon pain, weakness, dizziness or mood changes immediately.
For those already affected, community support is vital. Miriam Knight's group, founded in 2015, offers a lifeline to sufferers, reassuring them they are not alone or 'going mad.' Members share advice and comfort, without giving direct medical recommendations.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BreakingNews.ie
an hour ago
- BreakingNews.ie
Alcohol harm costing workplaces €8.5 billion in lost productivity
Alcohol abuse is costing Irish workplaces €8.5 billion a year in lost productivity, according to Alcohol Action Ireland (AAI). Alcohol Action Ireland (AAI), the national independent advocate to reduce alcohol harm, has published its latest report on the impact that alcohol has on the Irish economy and urges the government to implement policies that will reduce this heavy burden. Alcohol's impact on public health and the health service, on crime and the criminal justice system, and on road traffic collisions is well documented. Advertisement However, another area which is directly and indirectly affected by alcohol, but which has received far too little attention, is the workplace. AAI's latest report, titled Alcohol's Cost to the Workplace , uses national and international evidence to shine a light on the impact of alcohol in the workplace in Ireland, the scale of its impact on workers, on employers, and on the economy. The report found employers and businesses can sometimes be a major contributor themselves to alcohol use amongst workforces. However, there is a role for employers and the trade union movement to reduce this by ensuring positive work conditions including fair treatment, recognition, meaningful work, skill variety, autonomy, acquisition and use of skills, fair rewards, promotion opportunities, friendship formation, and social support from co-workers and supervisors. Advertisement Heavy drinking increases the risk of absenteeism, with high-risk drinkers 22 times more likely to be absent from work due to their alcohol use compared with lower-risk drinkers. Presenteeism – which is defined as being physically present at work but, due to a physical or emotional issue, being distracted to the point of reduced productivity – is more important for lost productivity than is absenteeism, with presenteeism accounting for 77 per cent of total lost productivity in the workplace, while absenteeism is responsible for 23 per cent. It is estimated that heavy drinking increases the risk of unemployment by as much as about five-fold compared with light drinking. Speaking about the report, AAI chief executive Dr Sheila Gilheany said: 'Alcohol is by far the most used psychoactive substance in the workforce, with people having harmful consumption patterns that increase their risk of social, legal, medical, occupational, domestic and economic problems. Advertisement More than half of Irish drinkers are classified as hazardous drinkers. Within that cohort of hazardous drinkers, there are 578,000 people with an alcohol use disorder (AUD), of which 90,000 are at a severe level. 'Alcohol poses a significant risk to workers, to businesses, to productivity and to the economy. "Workers under the influence of alcohol can be a danger to themselves and to others, especially in jobs which involve a high risk of injury. "Working under the influence of alcohol, or with a hangover, can increase the risk of accidents, injuries and absenteeism, along with tardiness at work and/or leaving work early, resulting in loss of productivity. It can also lead to the development of inappropriate behaviour at work, poor relations with colleagues, and low company morale. Advertisement Ireland Man (29) claims self-defence after beating 59-year... Read More 'The impact of alcohol on the workplace is multifaceted. It affects the individual in terms of mortality and morbidity, productivity, presenteeism, and absenteeism. It affects colleagues in terms of workload, and it affects employers in terms of businesses losses and competitiveness. "However, the workplace also represents a useful access point for health promotion, including for addressing alcohol-related harm. Implementing workplace interventions to reduce hazardous drinking levels can have a positive economic impact by reducing absenteeism, presenteeism, accidents and injuries.' Dr Gilheany said that alcohol harm is estimated to cost the Irish exchequer about 2.5 per cent of GDP every year – that is €14 billion for 2024 – in health, justice and lost productivity. Of this, the lion's share – 61 per cent or about €8.5 billion – is due to lost productivity. She said given alcohol's huge drain on the Irish economy, much more could be done by government to address these issues.


Daily Mail
2 hours ago
- Daily Mail
Mysterious blue brain found in autopsy linked to RFK Jr's 'miracle cure'
A substance touted by health secretary Robert F Kennedy Jr as a 'miracle cure-all' has been found to dramatically change the color of internal organs, according to a new study. Researchers at University Hospital Frankfurt in Germany examined the bodies of 11 people and discovered that methylene blue, a synthetic dye long used to treat conditions like malaria and methemoglobinemia. Methylene blue may also help combat other health problems, including urinary tract infections and depression, experts have said. During the autopsies, researchers discovered that the brains, hearts, lungs, and pancreases had turned a striking shade of blue. Even small doses, as little as 25 milligrams, roughly a quarter of a standard aspirin tablet, were enough to alter brain pigment, the team concluded. Some individuals had received 50 to 200 milligrams intravenously for medical conditions, with multiple doses given within 10 hours of death, and all showed discoloration of the brain and heart. The researchers emphasized that while the color changes darkened upon exposure to air during autopsies, the effect was not linked to the causes of death. Instead, it highlights how methylene blue persists in the body and can dramatically affect organ appearance, raising questions for forensic and medical examinations. The individuals who received methylene blue in the hospital were generally being treated for severe medical conditions, often involving life-threatening shock or critical illnesses. Most were in intensive care units (ICUs) for issues like septic shock from infections, heart failure, complications following surgeries, or severe COVID-19 infections. Hospital staff administered the dye intravenously as a last-resort treatment to improve blood flow and oxygen delivery when standard treatments failed. The startling discovery, published in the journal Forensic Science, Medicine and Pathology, was made while researchers were conducting an autopsy on a 72-year-old man and found his brain was blue. To understand why, they searched their institute's database of 15,820 autopsy records from 2000 to 2023, looking for similar cases of doctors finding 'blue-green,' 'greenish,' or 'turquoise' organs during autopsies. They found 11 cases, including the 72-year-old, where various organs throughout the body had this unusual color. In each case, they found that six of these individuals with blue organs had ingested or been given a dosage of methylene blue shortly before their deaths. The other five had received or ingested a medical dye called toluidine blue, a sedative called Rohypnol that contains the blue dye indigocarmine, or a cleaning agent with the blue dye Brilliant Blue FCF. Study authors in Germany found 6 people who received dosages of methylene blue while in the hospital had blue brains and hearts after death The patients had taken the medical dye as a last resort treatment for various illnesses, including COVID-19 Although RFK Jr has not publicly confirmed that he uses methylene blue, a February 2025 video showed the health secretary putting droplets of a cobalt-blue liquid into what looked like water. Recent studies have explored its use in fighting early-stage COVID-19 by potentially reducing viral damage and improving oxygen delivery. It's also been investigated for its ability to boost brain health, treat shock, and potentially as an anti-aging serum. Some research has even suggested it can kill cancer cells under specific conditions. In fact, actor Mel Gibson claimed three of his friends recovered from stage four cancer after taking a supplement regimen that included methylene blue. In fact, actor Mel Gibson claimed three of his friends recovered from stage four cancer after taking a supplement regimen that included methylene blue. The Daily Mail has requested a comment from RFK Jr and the Department of Health and Human Services about the findings and is awaiting a response. While medical professionals only use the dye in extreme cases, methylene blue has taken over TikTok and Instagram with claims it can sharpen focus and boost mood. Methylene blue is FDA approved to treat the rare blood disorder methemoglobinemia, though it has also been used off label for anti-aging and cancer Influencers have dubbed it 'brain fuel' and a 'limitless pill,' with some studies claiming it can also alleviate mental health issues. However, neuroscientist Anne-Sophie Fluri told the Daily Mail in June that many of the supposed benefits being promoted online are based on preliminary research using rodents or petri dishes, not conclusive human clinical trials. The US Food and Drug Administration (FDA) has issued a public safety warning about methylene blue's potential to cause serotonin syndrome when combined with common antidepressants like Prozac, Zoloft, or Cymbalta. Serotonin syndrome is a dangerous condition caused by too much serotonin in the body, leading to symptoms like confusion, high fever, seizures, and, in rare cases, death. Methylene blue can trigger this syndrome when taken with antidepressants because it blocks an enzyme that normally breaks down serotonin, causing a harmful buildup.


Times
2 hours ago
- Times
How eight second clip restored voice stolen by motor neurone disease
After 25 years a woman with motor neurone disease (MND) is able to speak in her own voice again thanks to an artificial intelligence programme and eight seconds of old audio. Sarah Ezekiel was left without the use of her voice and hands at the age of 34 having been diagnosed with MND shortly after the birth of her second child. Five years later, the advent of eye-gaze technology meant she could form words and sentences that would be 'spoken' by a computer. But growing up, her children Aviva and Eric only heard their mother speak through a robotic-sounding artificial voice. Voice-cloning technology and artificial intelligence that can fill in gaps in audio content mean that now, even her Cockney accent has been restored. 'After such a long time, I couldn't really remember my voice,' Ezekiel told BBC Access All. 'When I first heard it again, I felt like crying. It's a kind of miracle.'